Amphastar Pharmaceuticals...
38.47
0.55 (1.45%)
At close: Jan 14, 2025, 3:59 PM
38.60
0.34%
Pre-market Jan 15, 2025, 08:05 AM EST

Amphastar Pharmaceuticals Inc. Revenue Breakdown

Quarter Sep 30, 2024
Product and Service, Other Revenue 2.40M
Product and Service, Other Revenue Growth n/a
Product Revenue 188.82M
Product Revenue Growth n/a

Revenue by Geography

Quarter Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015
C Revenue 3.16M 1.48M 279.12M 234.32M 249.01M 243.29M
C Revenue Growth +113.44% -99.47% +19.12% -5.90% +2.35% n/a
U Revenue 333.09M 304.90M n/a n/a n/a n/a
U Revenue Growth +9.25% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 23.82M 22.30M 25.05M 21.74M 19.06M 19.00M 20.59M 16.10M 16.77M 15.73M 17.99M 14.70M 15.65M 18.69M 19.88M 15.82M 15.35M 19.95M 14.04M 13.98M 14.24M 15.42M 19.47M 16.41M 15.37M 13.54M 12.72M 10.85M 13.42M 13.83M 12.82M 12.19M 12.09M 10.79M 12.22M 10.02M 10.21M 12.78M 13.97M
Selling, General, and Administrative Revenue Growth +6.81% -10.98% +15.22% +14.04% +0.33% -7.74% +27.90% -3.98% +6.56% -12.53% +22.41% -6.13% -16.26% -5.94% +25.63% +3.08% -23.07% +42.09% +0.42% -1.83% -7.63% -20.80% +18.63% +6.77% +13.47% +6.49% +17.23% -19.16% -2.96% +7.90% +5.11% +0.84% +12.07% -11.72% +22.00% -1.83% -20.14% -8.55% n/a
Research and Development Revenue 21.08M 14.53M 14.23M 17.85M 16.66M 16.84M 19.82M 17.24M 18.51M 22.80M 16.22M 17.29M 10.76M 18.12M 14.77M 18.13M 17.64M 16.15M 15.30M 19.64M 18.61M 16.00M 14.61M 16.73M 11.34M 15.47M 14.26M 11.39M 10.04M 10.73M 11.25M 12.28M 9.72M 10.48M 8.39M 8.65M 11.12M 10.73M 6.57M
Research and Development Revenue Growth +45.02% +2.11% -20.25% +7.11% -1.06% -15.00% +14.96% -6.90% -18.79% +40.53% -6.15% +60.67% -40.63% +22.74% -18.57% +2.77% +9.26% +5.53% -22.10% +5.58% +16.32% +9.51% -12.71% +47.57% -26.69% +8.47% +25.16% +13.48% -6.45% -4.60% -8.37% +26.27% -7.22% +24.94% -3.07% -22.16% +3.65% +63.31% n/a
Sales and Marketing Revenue 8.99M 9.01M 9.37M 8.62M 6.41M 6.72M 7.11M 5.47M 4.78M 5.76M 5.52M 4.08M 4.75M 4.13M 4.54M 3.79M 3.67M 4.03M 3.29M 3.48M 3.22M 2.99M 3.14M 2.60M 1.96M 1.88M 1.72M 1.63M 1.76M 1.60M 1.48M 1.49M 1.29M 1.33M 1.35M 1.31M 1.17M 1.47M 1.52M
Sales and Marketing Revenue Growth -0.19% -3.83% +8.72% +34.52% -4.63% -5.50% +29.92% +14.38% -16.89% +4.29% +35.44% -14.12% +14.92% -8.99% +19.80% +3.10% -8.77% +22.22% -5.24% +7.92% +7.65% -4.74% +20.99% +32.25% +4.64% +9.01% +5.65% -7.23% +10.03% +7.91% -0.80% +15.49% -3.08% -1.48% +3.44% +11.61% -20.34% -3.42% n/a